The DOI matches its Crossref record; 349 of the 349 references it cites were found in a registry or an index.
Various AAV Serotypes and Their Applications in Gene Therapy: An Overview
Open accessAbstract
Despite scientific discoveries in the field of gene and cell therapy, some diseases still have no effective treatment. Advances in genetic engineering methods have enabled the development of effective gene therapy methods for various diseases based on adeno-associated viruses (AAVs). Today, many AAV-based gene therapy medications are being investigated in preclinical and clinical trials, and new ones are appearing on the market. In this article, we present a review of AAV discovery, properties, different serotypes, and tropism, and a following detailed explanation of their uses in gene therapy for disease of different organs and systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–349 of 349
Bouquet, C., Vignal Clermont, C., Galy, A., Fitoussi, S., Blouin, L., Munk, M. R., Valero, S., Meunier, S., Katz, B., Sahel, J. A., et al. (2019) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2018.6902 · Cited by 104
Adeno-Associated Virus Types 5 and 6 Use Distinct Receptors for Cell Entry
Seiler, M. P., Miller, A. D., Zabner, J., & Halbert, C. L. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.10 · Cited by 104
Zhang, Y. C., Pileggi, A., Agarwal, A., Molano, R. D., Powers, M. A., Brusko, T. M., Wasserfall, C. H., Goudy, K., Zahr, E., Poggioli, R., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.3.708 · Cited by 104
Cloning of an Avian Adeno-Associated Virus (AAAV) and Generation of Recombinant AAAV Particles
Bossis, I., & Chiorini, J. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.12.6799-6810.2003 · Cited by 103
Current issues in adeno-associated viral vector production
Merten, O.-W., Gény-Fiamma, C., & Douar, A. M. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302615 · Cited by 103
Cordier, L., Hack, A. A., Scott, M. O., Barton-Davis, E. R., Gao, G., Wilson, J. M., McNally, E. M., & Sweeney, H. L. (2000) · Molecular Therapy · doi:10.1006/mthe.1999.0019 · Cited by 103
Lin, D., Fantz, C. R., Levy, B. K., Rafi, M. A., Vogler, C. A., Wenger, D. A., & Sands, M. S. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.04.019 · Cited by 102
Liver gene therapy: advances and hurdles
Nguyen, T., & Ferry, N. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302373 · Cited by 102
Diverse IgG subclass responses to adeno‐associated virus infection and vector administration
Murphy, S. L., Li, H., Mingozzi, F., Sabatino, D. E., Hui, D. J., Edmonson, S. A., & High, K. A. (2009) · Journal of Medical Virology · doi:10.1002/jmv.21360 · Cited by 101
Gene therapy and type 1 diabetes mellitus
Chellappan, D. K., Sivam, N. S., Teoh, K. X., Leong, W. P., Fui, T. Z., Chooi, K., Khoo, N., Yi, F. J., Chellian, J., Cheng, L. L., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.138 · Cited by 101
Hermonat, P. L., Quirk, J. G., Bishop, B. M., & Han, L. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00311-6 · Cited by 98
Sevin, C., Benraiss, A., Dam, D. V., Bonnin, D., Nagels, G., Vérot, L., Laurendeau, I., Vidaud, M., Gieselmann, V., Vanier, M. T., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi425 · Cited by 98
AAV9 targets cone photoreceptors in the nonhuman primate retina
Vandenberghe, L. H., Bell, P., Maguire, A. M., Xiao, R., Hopkins, T. B., Grant, R., Bennett, J., & Wilson, J. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053463 · Cited by 97
A Single-Step Affinity Column for Purification of Serotype-5 Based Adeno-associated Viral Vectors
Auricchio, A., O'Connor, E., Hildinger, M., & Wilson, J. M. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0462 · Cited by 96
Adeno-Associated Virus Gene Therapy in a Sheep Model of Tay–Sachs Disease
Gray‐Edwards, H. L., Randle, A. N., Maitland, S. A., Benatti, H. R., Hubbard, S. M., Canning, P. F., Vogel, M. B., Brunson, B. L., Hwang, M., Ellis, L. E., et al. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.163 · Cited by 96
Zhu, T., Zhou, L., Mori, S., Wang, Z., McTiernan, C. F., Qiao, C., Chen, C., Wang, D. W., Li, J., & Xiao, X. (2005) · Circulation · doi:10.1161/circulationaha.105.565598 · Cited by 95
Zérah, M., Piguet, F., Colle, M.-A., Raoul, S., Deschamps, J., Deniaud, J., Gautier, B., Toulgoat, F., Bièche, I., Laurendeau, I., et al. (2015) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2014.139 · Cited by 93
Raake, P. W. J., Hinkel, R., Müller, S., Delker, S., Kreuzpointner, R., Kupatt, C., Katus, H. A., Kleinschmidt, J. A., Boekstegers, P., & Müller, O. J. (2007) · Gene Therapy · doi:10.1038/sj.gt.3303035 · Cited by 93
Piguet, F., Sondhi, D., Piraud, M., Fouquet, F., Hackett, N. R., Ahouansou, O., Vanier, M.-T., Bieche, I., Aubourg, P., Crystal, R. G., et al. (2012) · Human Gene Therapy · doi:10.1089/hum.2012.015 · Cited by 91
Qiao, C., Zhang, W., Yuan, Z., Shin, J., Li, J., Jayandharan, G. R., Li, Z., Srivastava, A., Xiao, X., & Duan, D. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.003 · Cited by 91
A lung tropic AAV vector improves survival in a mouse model of surfactant B deficiency
Kang, M. H., van Lieshout, L. P., Xu, L., Domm, J. M., Vadivel, A., Renesme, L., Mühlfeld, C., Hurskainen, M., Mižíková, I., Pei, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17577-8 · Cited by 91
Perturbation of the cell cycle by adeno-associated virus
Winocour, E., Callaham, M. F., & Huberman, E. (1988) · Virology · doi:10.1016/0042-6822(88)90100-6 · Cited by 90
Kodippili, K., Hakim, C. H., Pan, X., Yang, H. T., Yue, Y., Zhang, Y., Shin, J., Yang, N. N., & Duan, D. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.095 · Cited by 90
Manufacturing of recombinant adeno-associated viruses using mammalian expression platforms
Robert, M., Chahal, P. S., Audy, A., Kamen, A., Gilbert, R., & Gaillet, B. (2017) · Biotechnology Journal · doi:10.1002/biot.201600193 · Cited by 89
Custom Adeno-Associated Virus Capsids: The Next Generation of Recombinant Vectors with Novel Tropism
Muzyczka, N., & Warrington, K. H. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.408 · Cited by 89
Bradbury, A. M., Rafi, M., Bagel, J. H., Brisson, B. K., Marshall, M. S., Pesayco, J. P., Jiang, X., Swain, G. P., Prociuk, M. L., O’Donnell, P. A., et al. (2018) · Human Gene Therapy · doi:10.1089/hum.2017.151 · Cited by 88
Seroepidemiological and Ecological Studies of the Adenovirus-Associated Satellite Viruses
Parks, W. P., Boucher, D. W., Melnick, J. L., Taber, L. H., & Yow, M. D. (1970) · Infection and Immunity · doi:10.1128/iai.2.6.716-722.1970 · Cited by 86
Secreted and Transmembrane Mucins Inhibit Gene Transfer with AAV4 More Efficiently than AAV5
Walters, R. W., Pilewski, J. M., Chiorini, J. A., & Zabner, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200292200 · Cited by 86
Adeno-associated virus-mediated cancer gene therapy: Current status
Luo, J., Luo, Y., Sun, J., Zhou, Y., Zhang, Y., & Yang, X. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.10.045 · Cited by 86
Cloning and Characterization of a Bovine Adeno-Associated Virus
Schmidt, M., Katano, H., Bossis, I., & Chiorini, J. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6509-6516.2004 · Cited by 84
Treatment of lysosomal storage disease in MPS VII mice using a recombinant adeno-associated virus
Gl, W., Sayles, J., Chen, C., Elliger, S. S., Elliger, C., Raju, N. R., Kurtzman, G. J., & Podsakoff, G. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300775 · Cited by 83
Gurda, B. L., de Lataillade, A. D. G., Bell, P. L., Zhu, Y., Yu, H., Wang, P., Bagel, J. H., Vite, C. H., Sikora, T. U., Hinderer, C. J., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2015.189 · Cited by 82
Li, S., Ling, C., Li, Z., Li, M., Su, Q., He, R., Tang, Q., Greiner, D. L., Shultz, L. D., Brehm, M. A., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2015.174 · Cited by 82
Chowdhury, E. A., Meno‐Tetang, G. M. L., Chang, H. Y., Wu, S., Huang, H. W., Jamier, T., Chandran, J. S., & Shah, D. K. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.017 · Cited by 82
Efficient intracerebral delivery of AAV5 vector encoding human ARSA in non-human primate
Colle, M.-A., Piguet, F., Bertrand, L., Raoul, S., Bièche, I., Dubreil, L., Sloothaak, D., Bouquet, C., Moullier, P., Aubourg, P. R., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp475 · Cited by 80
A simplified purification protocol for recombinant adeno-associated virus vectors
Potter, M., Lins, B., Mietzsch, M., Heilbronn, R., Vliet, K. V., Chipman, P. R., Agbandje‐McKenna, M., Cleaver, B. D., Clément, N., Byrne, B. J., et al. (2014) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2014.34 · Cited by 79
Wang, B., Li, J., Fu, F. H., & Xiao, X. (2008) · Journal of Orthopaedic Research® · doi:10.1002/jor.20781 · Cited by 79
Bartoli, M., Roudaut, C., Martin, S., Fougerousse, F., Suel, L., Poupiot, J., Gicquel, E., Noulet, F., Danos, O., & Richard, I. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.09.017 · Cited by 79
Krabbe disease successfully treated via monotherapy of intrathecal gene therapy
Bradbury, A. M., Bagel, J. H., Nguyen, D. A., Lykken, E. A., Pesayco, J. P., Jiang, X., Swain, G. P., Assenmacher, C., Hendricks, I. J., Miyadera, K., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci133953 · Cited by 77
Matalon, R. K., Surendran, S., Rady, P. L., Quast, M. J., Campbell, G. A., Matalon, K. M., Tyring, S. K., Wei, J., Peden, C. S., Ezell, E. L., et al. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00066-2 · Cited by 76
Fougerousse, F., Bartoli, M., Poupiot, J., Arandel, L., Durand, M., Guerchet, N., Gicquel, E., Danos, O., & Richard, I. (2006) · Molecular Therapy · doi:10.1038/sj.mt.6300022 · Cited by 75
Lu, Y., Choi, Y., Campbell‐Thompson, M., Li, C., Tang, Q., Crawford, J. M., Flotte, T. R., & Song, S. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.896 · Cited by 75
Arbetman, A. E., Lochrie, M. A., Zhou, S., Wellman, J. A., Scallan, C. D., Doroudchi, M. M., Randlev, B., Patarroyo-White, S. L., Liu, T., Smith, P., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15238-15245.2005 · Cited by 75
Schmidt, M., Lakshmanan Govindasamy, A., Afione, S. A., Kaludov, N., Agbandje‐McKenna, M., & Chiorini, J. A. (2008) · Journal of Virology · doi:10.1128/jvi.00672-08 · Cited by 74
White, J. D., Thesier, D. M., Swain, J. B. D., Katz, M. G., Tomasulo, C., Henderson, A., Wang, L., Yarnall, C., Fargnoli, A., Sumaroka, M., et al. (2011) · Gene Therapy · doi:10.1038/gt.2010.168 · Cited by 73
Mizuno, M., Yoshida, J., Colosi, P., & Kurtzman, G. J. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb00482.x · Cited by 73
Ding, W., Yan, Z., Žák, R., Saavedra, M. T., Rodman, D. M., & Engelhardt, J. F. (2003) · Journal of Virology · doi:10.1128/jvi.77.13.7361-7366.2003 · Cited by 72
Adeno-associated Virus: A Key to the Human Genome?
Henckaerts, E., & Linden, R. M. (2010) · Future Virology · doi:10.2217/fvl.10.48 · Cited by 71
Takeda, S., Takahashi, M., Mizukami, H., Kobayashi, E., Takeuchi, K., Hakamata, Y., Kaneko, T., Yamamoto, H., Ito, C., Ozawa, K., et al. (2004) · Nephron Experimental Nephrology · doi:10.1159/000077378 · Cited by 68
Next Step in Gene Delivery: Modern Approaches and Further Perspectives of AAV Tropism Modification
Korneyenkov, M. A., & Zamyatnin, A. A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13050750 · Cited by 68
The Role of Recombinant AAV in Precise Genome Editing
Bijlani, S., Pang, K. M., Sivanandam, V., Singh, A., & Chatterjee, S. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.799722 · Cited by 68
The progress of AAV-mediated gene therapy in neuromuscular disorders
Aguti, S., Malerba, A., & Zhou, H. (2018) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1479739 · Cited by 67
Murillo, O., Moreno, D., Gázquez, C., Barberia, M., Cenzano, I., Navarro-Blasco, Í., Uriarte, I., Sebastián, V., Arruebo, M., Ferrer, V., et al. (2019) · Hepatology · doi:10.1002/hep.30535 · Cited by 67
Functional roles of the membrane-associated AAV protein MAAP
Galibert, L., Hyvönen, A., Eriksson, R. A. E., Mattola, S., Aho, V., Salminen, S., Albers, J., Peltola, S. K., Weman, S., Nieminen, T., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-01220-7 · Cited by 66
Direct Comparison of Administration Routes for AAV8-mediated Ocular Gene Therapy
Igarashi, T., Miyake, K., Asakawa, N., Miyake, N., Shimada, T., & Takahashi, H. (2013) · Current Eye Research · doi:10.3109/02713683.2013.779720 · Cited by 64
Haddad, G., Kölling, M., Wegmann, U. A., Dettling, A., Seeger, H., Schmitt, R., Sörensen-Zender, I., Haller, H. G., Kistler, A. D., Dueck, A., et al. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020060775 · Cited by 62
Cheng, B., Ling, C., Dai, Y., Lu, Y., Glushakova, L. G., Gee, S. W. Y., McGoogan, K. E., Aslanidi, G., Park, M., Stacpoole, P. W., et al. (2011) · Gene Therapy · doi:10.1038/gt.2011.105 · Cited by 61
Conlon, T. J., Cossette, T. L., Erger, K. E., Choi, Y., Clarke, T., Scott-Jorgensen, M., Song, S., Campbell‐Thompson, M., Crawford, J. M., & Flotte, T. R. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.05.016 · Cited by 61
Denby, L., Nicklin, S. A., & Baker, A. H. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302564 · Cited by 61
Chulay, J. D., Ye, G.-J., Thomas, D. L., Knop, D. R., Benson, J. M., Hutt, J. A., Wang, G., Humphries, M. R., & Flotte, T. R. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.118 · Cited by 60
De, B. P., Heguy, A., Leopold, P. L., Wasif, N., Korst, R. J., Hackett, N. R., & Crystal, R. G. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.08.022 · Cited by 58
Long-term Skeletal Muscle Protection After Gene Transfer in a Mouse Model of LGMD-2D
Pacak, C. A., Walter, G. A., Gaidosh, G., Bryant, N. D., Lewis, M. A., Germain, S. A., Mah, C. S., Campbell, K. P., & Byrne, B. J. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300246 · Cited by 58
Khatib, M. M. E., Sakuma, T., Tonne, J. M., Mohamed, M. S., Holditch, S. J., Lu, B., Kudva, Y. C., & Ikeda, Y. (2015) · Gene Therapy · doi:10.1038/gt.2015.18 · Cited by 57
Attachment of adeno-associated virus type 3H to fibroblast growth factor receptor 1
Blackburn, S. D., Steadman, R., & Johnson, F. B. (2005) · Archives of Virology · doi:10.1007/s00705-005-0650-6 · Cited by 57
Bish, L. T., Sleeper, M. M., Reynolds, C., Gazzara, J. A., Withnall, E., Singletary, G. E., Buchlis, G., Hui, D. J., High, K. A., Gao, G., et al. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.035 · Cited by 56
Rockwell, H. E., McCurdy, V. J., Eaton, S. C., Wilson, D. U., Johnson, A. K., Randle, A. N., Bradbury, A. M., Gray‐Edwards, H. L., Baker, H. J., Hudson, J. A., et al. (2015) · ASN NEURO · doi:10.1177/1759091415569908 · Cited by 56
Miyake, K., Miyake, N., Yamazaki, Y., Shimada, T., & Hirai, Y. (2012) · Journal of Nippon Medical School · doi:10.1272/jnms.79.394 · Cited by 55
Schievenbusch, S., Strack, I., Scheffler, M., Nischt, R., Coutelle, O., Hösel, M., Hallek, M. J., Fries, J., Dienes, H., Odenthal, M., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.71 · Cited by 55
Gene therapy for the treatment of cystic fibrosis
Davies, J. C., Burney, & Alton, E. W. F. W. (2012) · The Application of Clinical Genetics · doi:10.2147/tacg.s8873 · Cited by 54
Structural and cellular biology of adeno-associated virus attachment and entry
Zengel, J. R., & Carette, J. E. (2020) · Advances in virus research · doi:10.1016/bs.aivir.2020.01.002 · Cited by 54
Wang, R. L., McLaughlin, T., Cossette, T. L., Tang, Q., Foust, K. D., Campbell‐Thompson, M., Martino, A. T., Cruz, P. E., Loiler, S., Mueller, C., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.217 · Cited by 53
Han, Z., Luo, N., Ma, W., Liu, X., Cai, Y., Kou, J., Wang, J., Li, L., Peng, S., Xu, Z., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39554-7 · Cited by 53
Chiuchiolo, M. J., Kaminsky, S. M., Sondhi, D., Hackett, N. R., Rosenberg, J. B., Frenk, E. Z., Hwang, Y., de Graaf, B. G. V., Hutt, J. A., Wang, G., et al. (2013) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2013.168 · Cited by 52
Polyak, S., Mach, A. S., Porvasnik, S., Dixon, L. R., Conlon, T. J., Erger, K. E., Acosta, A. J., Wright, A. J., Campbell‐Thompson, M., Zolotukhin, I., et al. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00562.2010 · Cited by 52
Gene Therapy Potential for Genetic Disorders of Surfactant Dysfunction
Cooney, A. L., Wambach, J., Sinn, P. L., & McCray, P. B. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.785829 · Cited by 52
Karumuthil‐Melethil, S., Marshall, M. S., Heindel, C., Jakubauskas, B., Bongarzone, E. R., & Gray, S. J. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23882 · Cited by 51
Flotte, T. R., Conlon, T. J., Poirier, A. E., Campbell‐Thompson, M., & Byrne, B. J. (2007) · Human Gene Therapy · doi:10.1089/hum.2006.113 · Cited by 51
AAV-directed muscular dystrophy gene therapy
Tang, Y. M., Cummins, J. H., Huard, J., & Wang, B. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712591003604690 · Cited by 50
Hu, C., & Lipshutz, G. S. (2012) · Gene Therapy · doi:10.1038/gt.2011.200 · Cited by 48
Kurzeder, C., Koppold, B., Sauer, G., Pabst, S., Kreienberg, R., & Deißler, H. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.19.2.325 · Cited by 48
Treatment of experimental asthma by long-term gene therapy directed against IL-4 and IL-13
Zavorotinskaya, T., Tomkinson, A., & Murphy, J. E. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(02)00050-3 · Cited by 47
Ling, C., Wang, Y., Zhang, Y., Ejjigani, A., Yin, Z., Lu, Y., Wang, L., Wang, M., Li, J., Hu, Z., et al. (2014) · Human Gene Therapy · doi:10.1089/hum.2014.099 · Cited by 45
Marcó, S., Haurigot, V., Jaén, M. L., Ribera, A., Sánchez, V., Molas, M., Garcia, M., León, X., Roca, C., Sánchez, X., et al. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.09.017 · Cited by 45
Cabanes‐Creus, M., Navarro, R. G., Zhu, E., Baltazar, G., Liao, S. H. Y., Drouyer, M., Amaya, A. K., Scott, S., Nguyen, L. H., Westhaus, A., et al. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.11.011 · Cited by 45
Influence of adeno-associated virus on adherence and growth properties of normal cells
Bantel‐Schaal, U., & Stöhr, M. (1992) · Journal of Virology · doi:10.1128/jvi.66.2.773-779.1992 · Cited by 44
Kurai, T., Hisayasu, S., Kitagawa, R., Migita, M., Suzuki, H., Hirai, Y., & Shimada, T. (2006) · Molecular Therapy · doi:10.1038/sj.mt.6300012 · Cited by 44
Sun, A., Tang, J., Terranova, P. F., Zhang, X., Thrasher, J. B., & Li, B. (2009) · International Journal of Cancer · doi:10.1002/ijc.24778 · Cited by 44
Wu, Q. J., Gong, C. Y., Luo, S. T., Zhang, D. M., Zhang, S., Shi, H., Lu, L., Yan, H., He, S., Li, D. D., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-129 · Cited by 43
Halbert, C. L., Madtes, D. K., Vaughan, A. E., Wang, Z., Storb, R. F., Tapscott, S. J., & Miller, A. D. (2010) · Molecular Therapy · doi:10.1038/mt.2010.51 · Cited by 42
Kanazawa, T., Mizukami, H., Okada, T., Hanazono, Y., Kume, A., Nishino, H., Takeuchi, K., Kitamura, K., Ichimura, K., & OZAWA, K. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301837 · Cited by 42
Miyake, N., Miyake, K., Asakawa, N., Yamamoto, M., & Shimada, T. (2014) · Gene Therapy · doi:10.1038/gt.2014.17 · Cited by 42
Loiler, S., Tang, Q., Clarke, T., Campbell‐Thompson, M., Chiodo, V. A., Hauswirth, W. W., Cruz, P. E., Perret-Gentil, M., Atkinson, M. A., Ramiya, V. K., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.04.017 · Cited by 40
Canavan disease: a monogenic trait with complex genomic interaction
Surendran, S., Michals‐Matalon, K., Quast, M. J., Tyring, S. K., Wei, J., Ezell, E. L., & Matalon, R. K. (2003) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2003.08.015 · Cited by 40
Immune function in X-linked retinoschisis subjects in an AAV8-RS1 phase I/IIa gene therapy trial
Mishra, A., Vijayasarathy, C., Cukras, C. A., Wiley, H. E., Sen, H. N., Zeng, Y., Wei, L. L., & Sieving, P. A. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.02.013 · Cited by 38
Genetic Modification of the Lung Directed Toward Treatment of Human Disease
Sondhi, D., Stiles, K. M., De, B. P., & Crystal, R. G. (2017) · Human Gene Therapy · doi:10.1089/hum.2016.152 · Cited by 36
Tse, L. Y., Sun, X., Jiang, H., Dong, X., Fung, P. C. W., Farzaneh, F., & Xu, R. (2008) · The Journal of Gene Medicine · doi:10.1002/jgm.1180 · Cited by 36
Han, Z., Li, Z., Maina, N., Hu, Z., Li, X., Chouthai, N. S., Bischof, D., Weigel-Kelley, K. A., Slayton, W. B., Yöder, M. C., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.161 · Cited by 35
Qi, Y., Li, Q. H., Shenoy, V., Zingler, M., Jun, J. Y., Verma, A., Katovich, M. J., & Raizada, M. K. (2012) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12037 · Cited by 35
Mitchell, M., Nam, H.-J., Carter, A., McCall, A. L., Rence, C., Bennett, A. D., Gurda, B. L., McKENNA, R. V., Porter, M., Sakai, Y., et al. (2009) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309109021460 · Cited by 35
Sevin, C., Roujeau, T., Cartier, N., Baugnon, T., Adamsbaum, C., Piraud, M., Martino, S., Mouiller, P., Couzinié, C., Bellesme, C., et al. (2018) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2017.12.352 · Cited by 34
Optimization of adeno-associated virus vector-mediated gene transfer to the respiratory tract
Kurosaki, F., Uchibori, R., Mato, N., Sehara, Y., Saga, Y., Urabe, M., Mizukami, H., Sugiyama, Y., & Kume, A. (2017) · Gene Therapy · doi:10.1038/gt.2017.19 · Cited by 33
Zhang, L., Rossi, A., Lange, L., Meumann, N., Koitzsch, U., Christie, K. A., Nesbit, M. A., Moore, C. B. T., Hacker, U. T., Morgan, M. A., et al. (2019) · Human Gene Therapy · doi:10.1089/hum.2019.027 · Cited by 33
Progress in Respiratory Gene Therapy
McLachlan, G., Alton, E. W. F. W., Boyd, A., Clarke, N. K., Davies, J. C., Gill, D. R., Uta Griesenbach, D., Hickmott, J. W., Hyde, S. C., Miah, K. M., et al. (2022) · Human Gene Therapy · doi:10.1089/hum.2022.172 · Cited by 33
Successful Transfection of Genes Using AAV-2/9 Vector in Swine Coronary and Peripheral Arteries
Pankajakshan, D., Makinde, T. O., Gaurav, R., Core, M. A. D., Hatzoudis, G., Pipinos, I. I., & Agrawal, D. K. (2011) · Journal of Surgical Research · doi:10.1016/j.jss.2011.02.032 · Cited by 32
Qiu, J., & Pintel, D. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312734200 · Cited by 32
Denard, J., Marolleau, B., Jenny, C., Rao, T. N., Fehling, H. J., Voit, T., & Svinartchouk, F. (2013) · Journal of Virology · doi:10.1128/jvi.01813-13 · Cited by 31
Lin, D., Hsiao, C., Liau, I., Lin, S.-P., Chiang, M., Chuang, C., Wang, T.-J., Wu, T., Jian, Y.-R., Huang, S., et al. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.05.005 · Cited by 31
Su, H., Yeghiazarians, Y., Lee, A., Huang, Y.-W., Arakawa-Hoyt, J. S., Ye, J., Orcino, G., Grossman, W., & Kan, Y. W. (2007) · The Journal of Gene Medicine · doi:10.1002/jgm.1129 · Cited by 31
White, A. F., Mazur, M., Sorscher, E. J., Zinn, K. R., & Ponnazhagan, S. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.117 · Cited by 31
Quinn, K., Quirion, M. R., Lo, C.-Y., Misplon, J. A., Epstein, S. L., & Chiorini, J. A. (2011) · Molecular Therapy · doi:10.1038/mt.2011.146 · Cited by 30
Adeno-associated virus (AAV) vectors for gene transfer
Xiao, X., deVlaminck, W., & Monahan, J. (1993) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(93)90060-h · Cited by 29
Lane, M. D., Nam, H.-J., Padron, E., Gurda, B. L., Kohlbrenner, E., Aslanidi, G., Byrne, B. J., McKENNA, R. V., Muzyczka, N., Zolotukhin, S., et al. (2005) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309105014132 · Cited by 28
Strategies to generate high-titer, high-potency recombinant AAV3 serotype vectors
Ling, C., Yin, Z., Li, J., Zhang, D., Aslanidi, G., & Srivastava, A. (2016) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2016.29 · Cited by 28
Capsid-Modified Adenoviral Vectors for Improved Muscle-Directed Gene Therapy
Guse, K., Suzuki, M., Sule, G. J., Bertin, T., Tyynismaa, H., Ahola, S., Palmer, D. J., Suomalainen, A., Ng, P., Cerullo, V., et al. (2012) · Human Gene Therapy · doi:10.1089/hum.2012.003 · Cited by 27
New perspectives for gene therapy in endocrinology
Barzon, L., Bonaguro, R., Palù, G., & Boscaro, M. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430447 · Cited by 27
Kahle, N. A., Peters, T. M., Zobor, D., Kuehlewein, L., Kohl, S., Zhour, A., Werner, A., Seitz, I. P., Sothilingam, V., Michalakis, S., et al. (2018) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2018.088 · Cited by 27
7T MRI Predicts Amelioration of Neurodegeneration in the Brain after AAV Gene Therapy
Gray‐Edwards, H. L., Maguire, A. S., Salibi, N., Ellis, L. E., Voss, T. L., Diffie, E. B., Koehler, J. W., Randle, A. N., Taylor, A. R., Brunson, B. L., et al. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.11.023 · Cited by 27
Isolation of an Adenovirus and an Adeno-Associated Virus from Goat Kids with Enteritis
Olson, E. J., Haskell, S. R. R., Frank, R. K., Lehmkuhl, H. D., Hobbs, L. A., Warg, J. V., Landgraf, J. G., & Wünschmann, A. (2004) · Journal of Veterinary Diagnostic Investigation · doi:10.1177/104063870401600518 · Cited by 25
Dutta, S. K. (1975) · American Journal of Veterinary Research · doi:10.2460/ajvr.1975.36.03.247 · Cited by 25
Intrapleural Gene Therapy for Alpha-1 Antitrypsin Deficiency-Related Lung Disease
Stiles, K. M., Sondhi, D., Kaminsky, S. M., De, B. P., Rosenberg, J. B., & Crystal, R. G. (2018) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.5.4.2017.0160 · Cited by 25
Shen, X., Xu, Y., Bai, Z., Ma, D., Niu, Q., Meng, J., Fan, S., Zhang, L., Hao, Z., Zhang, X., et al. (2018) · Human Gene Therapy Methods · doi:10.1089/hgtb.2018.148 · Cited by 25
Mezzina, M., & Merten, O. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-095-9_9 · Cited by 24
Shi, X., Aronson, S. J., ten Bloemendaal, L., Duijst, S., Bakker, R. S., de Waart, D. R., Bortolussi, G., Collaud, F., Elferink, R. P. J. O., Muro, A. F., et al. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.11.016 · Cited by 24
Redosing Adeno-Associated Virus Gene Therapy to the Central Nervous System
McElroy, A. W., Sena‐Esteves, M., Arjomandnejad, M., Keeler, A. M., & Gray‐Edwards, H. L. (2022) · Human Gene Therapy · doi:10.1089/hum.2022.170 · Cited by 24
Mori, S., Takeuchi, T., Enomoto, Y., Kondo, K., Sato, K., Ono, F., Sata, T., & Kanda, T. (2007) · Archives of Virology · doi:10.1007/s00705-007-1097-8 · Cited by 23
Mucopolysaccharidosis III: Molecular basis and treatment
Spahıu, L., Behluli, E., Peterlin, B., Nefić, H., Hadžiselimović, R., Liehr, T., & Temaj, G. (2021) · Pediatric Endocrinology Diabetes and Metabolism · doi:10.5114/pedm.2021.109270 · Cited by 23
Lu, L., Luo, S., Shi, H., Li, M., ZHANG, H. L., He, S., Liu, Y., Pan, Y., & Li, Y. (2012) · Oncology Reports · doi:10.3892/or.2012.1915 · Cited by 22
Cataldi, M. P., & McCarty, D. M. (2012) · Gene Therapy · doi:10.1038/gt.2012.86 · Cited by 21
Flores, R. R., Zhou, L., & Robbins, P. D. (2014) · Gene Therapy · doi:10.1038/gt.2014.45 · Cited by 20
Zhang, C., Freistaedter, A., Schmelas, C., Gunkel, M., Thi, V. L. D., & Grimm, D. (2021) · Hepatology Communications · doi:10.1002/hep4.1842 · Cited by 20
Gene Therapy for Cystic Fibrosis Paved the Way for the Use of Adeno-Associated Virus in Gene Therapy
Guggino, W. B., & Cebotaru, L. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.046 · Cited by 18
Correction: AAV9 Targets Cone Photoreceptors in the Nonhuman Primate Retina
Vandenberghe, L. H., Bell, P., Maguire, A. M., Xiao, R., Hopkins, T. B., Grant, R., Bennett, J., & Wilson, J. M. (2013) · PLoS ONE · doi:10.1371/annotation/64b90996-4634-4c63-b737-634397b0b445 · Cited by 16
Darbey, A. L., Rebourcet, D., Curley, M. K., Kilcoyne, K. R., Jeffery, N., Reed, N., Milne, L., Roesl, C., Brown, P., & Smith, L. B. (2020) · Andrology · doi:10.1111/andr.12915 · Cited by 16
AAV-Mediated Gene Editing via Double-Strand Break Repair
Hirsch, M. L., & Samulski, R. J. (2014) · Methods in molecular biology · doi:10.1007/978-1-62703-761-7_19 · Cited by 15
Zolgensma - one-time gene therapy for spinal muscular atrophy.
(2019) · PubMed · Cited by 14
Prospects for Research for Disorders of the Endocrine System
Wilson, J. D. (2001) · JAMA · doi:10.1001/jama.285.5.624 · Cited by 13
Rizvanov, A. A., Shaimardanova, A. A., Chulpanova, D. S., Solovyeva, V. V., & Аймалетдинов, А. М. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.314310 · Cited by 13
Self-citationKrabbe Disease: Prospects of Finding a Cure Using AAV Gene Therapy
Nasir, G., Chopra, R., Elwood, F., & Ahmed, S. S. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.760236 · Cited by 13
Gene delivery to cone photoreceptors by subretinal injection of rAAV2/6 in the mouse retina
Hori, T., Fukutome, M., Maejima, C., Matsushima, H., Kobayashi, K., Kitazawa, S., Kitahara, R., Kitano, K., Kobayashi, K., Moritoh, S., et al. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.05.117 · Cited by 12
Zieger, M. V., Borel, F., Greer, C., Gernoux, G., Blackwood, M., Flotte, T. R., & Mueller, C. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.04.003 · Cited by 12
Stutika, C., Hüser, D., Weger, S., Rutz, N., Heßler, M., & Heilbronn, R. (2014) · Journal of General Virology · doi:10.1099/vir.0.000034 · Cited by 11
Systemic AAV10.COMP-Ang1 rescues renal glomeruli and pancreatic islets in type 2 diabetic mice
Tian, M., Carroll, L. S., Tang, L., Uehara, H., Westenfelder, C. S., Ambati, B. K., & Huang, Y. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000882 · Cited by 11
Isolation and Identification of a Bovine Adenovirus Type 3 with an Adenovirus-Associated Virus
Coria, M. F., & Lehmkuhl, H. D. (1978) · American Journal of Veterinary Research · doi:10.2460/ajvr.1978.39.12.1904 · Cited by 11
Neutralizing the Neutralizers in AAV Gene Therapy
Herzog, R. W., & Biswas, M. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.07.015 · Cited by 10
Chimeric AAV Cap sequences alter gene transduction
Ward, P., & Walsh, C. (2009) · Virology · doi:10.1016/j.virol.2009.01.012 · Cited by 9
Advances and challenges in the use of recombinant AAV vectors for human gene therapy
Srivastava, A. (2016) · Cell and Gene Therapy Insights · doi:10.18609/cgti.2016.061 · Cited by 8
Almaghrabi, S. A., Azzouz, M., & Ahnini, R. T. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1166 · Cited by 8
Efficacy and safety of gene therapy with AAV4 in childhood blindness due to rpe65 mutations
Meur, G. L., Lebranchu, P., Péréon, Y., Billaud, F., Ivan, C., Chauveau, C., Rolling, F., & Weber, M. (2012) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2012.4223.x · Cited by 4
116. The Proposed AAV Serotypes 10 and 11 Serologically Cross-React with AAV8 and AAV4
Vandenberghe, L. H., Miller, J. R., Gao, G.-P., Calcedo, R., & Wilson, J. M. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.08.136 · Cited by 1
Cited by
Adeno-associated virus as a delivery vector for gene therapy of human diseases
Wang, J.-H., Gessler, D. J., Zhan, W., Gallagher, T. L., & Gao, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01780-w · Cited by 904
Innate immune sensing of adeno-associated virus vectors
Cao, D., Byrne, B. J., de Jong, Y. P., Terhorst, C., Duan, D., Herzog, R. W., & Kumar, S. R. P. (2024) · Human Gene Therapy · doi:10.1089/hum.2024.040 · Cited by 50
Kitaeva, K. V., Solovyeva, V. V., Blatt, N. L., & Rizvanov, A. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25010643 · Cited by 7
Self-citation
Metadata
- Authors
- Issa, S. S., Shaimardanova, A. A., Solovyeva, V. V., & Rizvanov, A. A.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2023-03-01
- Volume
- 12
- Issue
- 5
- Pages
- 785
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W4322770338
- Cited by
- 313
- References
- 349
- FWCI
- 45.85
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.